CClinicalTrials.gg
Status unknownNCT01972633Updated Oct 30, 2013

Endoluminale Obliteration Der Stammvene Mit Dem 1470nm Laser Versus VNUS Closure Fast

A Phase 1/2 interventional study of Laser and Radiofrequency in Venous Insufficiency, sponsored by Ludwig Boltzmann Institute for Operative Laparoscopy. Status unknown at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-10-30.

Sponsored by Ludwig Boltzmann Institute for Operative Laparoscopy · Phase 1/2, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Oct 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Phase 1/2
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

There is a difference concerning obliteration rate and postoperative pain after treatment of the saphenous vein with 1470nm laser or VNUS Closure Fast (=radiofrequency method) .

Read the detailed description

The endovenous treatment of the insufficient saphenous vein (large saphenous vein and small saphenous vein) is a standard procedure for years. There are different methods that cause an obliteration of the vein using heat. The adventage of these methods are low rates of minor and major complications compared to classic open surgery. There are also advantages concerning cosmetic and recurrence of varicous veins. Actually there are two different methods for the endovenous obliteration of the saphenous vein - lasers with wavelength of 1470nm or 1320nm and the radiofrequency method. The objective of this study is to compare these two different methods concerning postoperative pain, obliteration rate and the rate of pleased patients in 140 patients. All patients get an venous ultrasound investigation to determine the stadium of venous insufficiency. There are consecutive ultrasound investigations 10 days, 3 months and 12 months after surgical treatment.

In this study there are no additional risk factors for the included study patients except the risk of surgery.

02

Conditions studied

  • Venous Insufficiency

Browse trials for

Keywords

  • endovenous treatment
  • Laser, Vnus Closure Fast
  • Varicosis
  • great saphenous vein
  • small saphenous vein
  • Venous Insufficiency
03

In context

Venous Insufficiency

189 studies on the registry are indexed under Venous Insufficiency; 16 are open to participants now.

This study's planned enrollment of 140 is above the median of 60 across 139 interventional studies indexed under Venous Insufficiency.

Browse Venous Insufficiency studies →

Lead sponsor

This is the only study on the registry with Ludwig Boltzmann Institute for Operative Laparoscopy as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • varicosis of great saphenous vein Hach-classification II-III (CEAP-classification: C3-4EPAS2-3PR and/or varicosis of small saphenous vein der Hach-classification I-III CEAP-classification: C3-4EPAS4PR)
  • maximum diameter of the great saphenous vein of 15mm maximum diameter of the small saphenous vein of 12mm

Exclusion criteria

Exclusion Criteria:

  • surgical treatment of the saphenous vein in the past
  • sclerotherapy of the saphenous vein in the past
  • phlebitis or thrombosis of the saphenous vein
  • surgical treatment of an venous ulcer in the past
  • postthrombotic syndrome
  • erysipelas of the leg in the past
  • chronic treatment with pain-killers or chronic alcoholism
  • pregnancy
  • drug allergy against painkillers that are used in this study
  • spinal anesthesia not possible
  • compression bandage not possible
  • patients with polyneuropathy
  • patients with chronic pain
  • persons that do have a connection or persons that are working for one of the jused companies (Laser or VNUS Closure Fast)
  • participation on an other clinical trial that can interfere with this clinical trial
  • missing written informed consent
05

Study design

Phase
Phase 1 / Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
140 participants (estimated)

Study arms

  • Active comparator
    1470nm Laser

    Patient with varicose vein treated with 1470nm Laser (Biolitec)

    Procedure: Laser · Procedure: Radiofrequency

  • Active comparator
    VNUS Closure Fast

    Patient with varicose vein treated with VNUS Closure Fast (Radiofrequency System)

    Procedure: Laser · Procedure: Radiofrequency

Interventions

  • ProcedureLaser

    Endovenous Laser (1470nm) ablation of great or small saphenous vein

  • ProcedureRadiofrequency

    Endovenous Radiofrequency (VNUS Closure Fast) of great or small saphenous vein

06

What researchers measure

Primary outcomes

  1. Pain

    Pain (visual analogue scale) on the day of treatment

    Time frame: day 0

Secondary outcomes

  1. Obliteration of the treated vein (GSV or SSV)

    An ultrasound investigation of he treated vein is done to find out if the treated vein is fully obliterated or not. If it is not fully obliterated we want to find out if there is any pathological reflux in the vein.

    Time frame: day 10, month 3, month 12

  2. Patient´s satisfaction after the intervention

    The patient is asked about his/her satisfaction after intervention. This is measured on a numeric scale from 1 to 5 (like schoolmarks in austria or germany). 1=very good, 2=good, 3=average, 4=not so good, 5=bad)

    Time frame: day 10, month 3, month 12

Other outcomes

  1. paresthesia of the lower leg after intervention

    patients are asked if there is any paresthesia of the lower leg - "yes" or "no"

    Time frame: day 10, month 3, month 12

07

Study locations

1 of 1 sites recruiting
  • 2.Chirurgische Abteilung AKh Linz GesmbH
    Linz, Oberösterreich 4020, Austria
    • Katharina Bröderbauer · Contact · chirurgie2@akh.linz.at · 0043 732 7806 2133
    • Markus MS Schreiner · Principal investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 30, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01972633
Lead sponsor
Ludwig Boltzmann Institute for Operative Laparoscopy
Responsible party
Dr. Markus Schreiner (Oberarzt, Ludwig Boltzmann Institute for Operative Laparoscopy) — Principal investigator
First posted
Oct 30, 2013
Start date
Jun 2010
Primary completion
Mar 2014 (estimated)
Completion
Apr 2014 (estimated)
Last update
Oct 30, 2013

Study contacts

Markus Schreiner
Contact
office@chirurgie-schreiner.at
0043 732 7806 73295
Andreas Shamiyeh
Contact
andreas.shamiyeh@akh.linz.at
0043 732 7806 2133
Markus Schreiner
principal investigator · 2.Chirurgische Abteilung AKh Linz GesmbH
Andreas Shamiyeh
study chair · 2. Chirurgische Abteilung AKh Linz GesmbH

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion